CardioAcademic,
Editors’ Insights: What is the impact of beta-blockers on breast cancer patients receiving anthracycline chemotherapy? New…
Editors’ Insights: What is the impact of beta-blockers on breast cancer patients receiving anthracycline chemotherapy? New…
Editors’ Insights: What is the impact of beta-blockers on breast cancer patients receiving anthracycline chemotherapy? New…
Editors’ Insights: What is the impact of beta-blockers on breast cancer patients receiving anthracycline chemotherapy? New…
Carvedilol for Prevention of Chemotherapy-Related #Cardiotoxicity The CECCY Trial https://t.co/WKFZPsDle3?amp=1
αおよびβ遮断薬である carvedilol は、乳がん化学療法 (anthracycline + cyclophosphamide → taxane) による left ventricular ejection fraction (LVEF) の低下を抑制…
Cardiac Agents May Protect Heart from Breast Cancer Tx: Two studies support possible prophylactic benefits of beta-blocker, ACE…
#ACC18 late-breaking CECCY trial shows incidence of early onset #cardiotoxicity with contemporary doses of #anthracycline was…